查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
导管市场 - COVID-19 的增长、趋势、影响和预测 (2023-2028)
市场调查报告书
商品编码
1190244

导管市场 - COVID-19 的增长、趋势、影响和预测 (2023-2028)

Catheters Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 110 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在预测期内 (2022-2027)，导管市场预计将以 7.7% 的复合年增长率增长。

随着 COVID-19 病例数量的增加和世界各地出现封锁条件，治疗、诊断和手术等服务最初被搁置以防止 COVID-19 的传播并进入市场。它有一个大的影响。 然而，全球 COVID-19 病例数量的增加导致住院人数增加。 随着政府和医疗机构发现更有效的医疗服务来治疗 COVID-19 患者，导管的使用在医院和急诊室显示出巨大的需求。 疑似或确诊 COVID-19 的患者使用导管进行治疗，在大流行期间对这些产品的需求仍然巨大。 此外，预计在大流行期间推出产品也将对市场增长产生积极影响。 例如，2020 年 4 月，Bactiguard 宣布推出一种新型导尿管 BIP Foley TempSensor，用于对患者进行持续体温监测。 这些因素共同推动了大流行期间的市场增长。

由于心血管、神经和泌尿系统疾病的负担不断增加，微创手术的使用越来越多，以及对抗菌导管的需求不断增加，预计该市场将经历良好的增长。 不断增加的慢性病是全球死亡率和发病率的主要原因。 根据脑动脉瘤基金会 2021 年 3 月的数据，全球每年约有 50 万人死于脑动脉瘤，其中一半年龄在 50 岁以下。 年破裂率约为每 100,000 人 8 至 10 人，或在美国约为 30,000 人。 因此，神经血管导管装置的需求预计会随着神经血管疾病的增加而增加。

此外，微创手术的增加预计将增加全球对导管的需求。 这些手术增加了患者对微创手术的偏好，预计这将有利于市场的增长。 此外，主要市场参与者加大力度推出产品，预计将进一步推动市场增长。 例如，2021年7月，美敦力公司在获得CE（Conformite Europeenne）标誌后，在欧洲推出了Prevail药物涂层球囊（DCB）导管。 市场上最新的冠状动脉 DCB，Prevail DCB，用于经皮冠状动脉介入治疗 (PCI) 手术，以治疗冠状动脉疾病 (CAD) 患者的冠状动脉狭窄或阻塞。 这将增加采用此类导管治疗心血管疾病，市场增长将受益于微创手术的上升趋势。

因此，随着慢性病病例的增加，手术数量的增加，预计在不久的将来对导管的需求将增加，从而推动市场的增长。 然而，与导管相关的并发症和替代品的存在可能会阻碍市场增长。

主要市场趋势

在预测期内，导尿管板块有望对收益和预测产生重大影响

当自主排尿困难时，需要导尿管。 由于泌尿系统疾病的患者使用该产品，因此泌尿系统疾病的发病率不断增加，预计该产品在预测期内将呈现高增长。

COVID-19 病例数量的增加在全球范围内造成了严重的破坏，并且还影响了患者群体对导尿管的需求。 导尿管用于外科手术，由于当局试图为 COVID-19 患者预留资源，各种择期手术被暂时推迟，一定程度上影响了需求。 然而，不断上升的感染率导致推出了几种产品，这些产品有助于该细分市场的稳定增长。 此外，根据 2020 年 10 月发表的一项题为“中国女性尿失禁患病率及相关因素：文献综述”的研究，有 43 至 349 名中国女性患有尿失禁 (UI)。估计达到 10,000人们。 尿失禁患病率的上升和外科手术的增加是推动导尿管需求的主要因素，这反过来又促进了这一领域的增长。

此外，预计在预测期内，导尿管监管审批的增加将进一步推动该细分市场的增长。 例如，2021 年 11 月，Flume Catheter Company Ltd. (TFCC) 获得美国食品药品监督管理局 (FDA) 的批准，可以在美国销售 FLUME 导尿管。

因此，由于上述因素，预计泌尿外科导管部分在预测期内将呈现增长。

预计在预测期内北美将占据较大的市场份额

在预测期内，北美地区预计将在导管市场占据重要的市场份额。 由于政府对医疗设备的高度支持和手术数量的增加，预计美国将主导市场。 推动市场增长的其他因素包括泌尿系统和心血管疾病的增加，以及由于手术时间更短和并发症更少而越来越倾向于微创手术。

根据美国癌症协会2022年的统计数据，估计2022年美国人将有大约81,180例膀胱癌新发病例。 预计这将增加导管在膀胱癌治疗中的应用，推动该地区的市场增长。

主要市场参与者对新产品发布的更多承诺预计也将进一步推动该地区的市场。 例如，2022年3月，Cerus Endovascular的027微导管获得了美国食品药品监督管理局（FDA）的批准，该微导管有两种长度可供选择，并且包括已经获得FDA批准的021微导管平台，公司的产品组合得到了扩展。 同样，2021 年 2 月，加拿大卫生部批准了 Bactguard 设计的 TempSensor 导管。

因此，扩大产品批准，加上美国患者人数的急剧增加，往往会增加对导管的需求，从而推动该地区的整体市场增长。

竞争格局

导管市场竞争激烈，许多公司都专注于开发先进的导管。 许多製造商与领先的医疗设备分销商合作，在全球或选定的国家/地区营销和分销他们的产品。 各种现有企业也采用了一些有机和无机增长战略来增加他们的市场份额。 此外，产品发布、併购和合作是这些公司为实现持续增长而采取的主要战略。 该市场的主要参与者包括 B. Braun Melsungen AG、Coloplast、ConvaTec Group、Hollister Incorporated、Medtronic PLC、Teleflex 和 Boston Scientific Corporation。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 3 个月的分析师支持

内容

第一章介绍

  • 研究假设和市场定义
  • 调查范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

  • 市场概览
  • 市场驱动力
    • 增加心血管、神经和泌尿系统疾病的负担
    • 微创手术的使用增加
    • 对抗菌导管的需求不断增长
  • 市场製约因素
    • 与导管相关的风险和并发症
    • 存在替代方案
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模：100 万美元）

  • 按产品分类
    • 心血管导管
    • 泌尿导管
    • 静脉导管
    • 神经血管导管
    • 其他产品
  • 最终用户
    • 医院
    • 疗养院
    • 其他最终用户
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东和非洲
      • 海湾合作委员会
      • 南非
      • 其他中东和非洲地区
    • 南美洲地区
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章竞争格局

  • 公司简介
    • B. Braun Melsungen AG
    • Coloplast
    • ConvaTec Group□
    • Hollister Incorporated
    • Medtronic PLC
    • Teleflex
    • Boston Scientific Corporation
    • Biotronik
    • Abbott Laboratories
    • Edwards Lifesciences Corporation
    • Johnson & Johnson（DePuy Synthes）
    • Terumo Corporation
    • Becton, Dickinson and Company（C.R. Bard）

第7章 市场机会与今后动向

简介目录
Product Code: 67961

The Catheters Market is poised to register a CAGR of 7.7% during the forecast period (2022-2027).

The rising COVID-19 cases across the world and the lockdown situation have had a significant impact on the market, initially due to on-hold services, such as treatment, diagnostic, and surgical services, to prevent the spread of COVID-19. However, the growing number of COVID-19 cases around the world has helped in increasing the number of in-patient admissions. As governments and healthcare institutions were found to increase efficient medical treatment to treat COVID-19 patients, the usage of catheters witnessed tremendous demand in hospitals and emergency clinics. Patients with suspected or confirmed diagnoses of COVID-19 were being treated with the help of catheters, and hence, the demand for these products remained huge throughout the pandemic. Moreover, product launches amid the pandemic were also anticipated to have a positive impact on the market's growth. For instance, in April 2020, Bactiguard introduced a new urinary catheter, the BIP Foley TempSensor, for continuous temperature monitoring in patients. Such factors collectively bolstered the market's growth over the pandemic phase.

The market is expected to observe good growth due to the increasing burden of cardiovascular, neurologic, and urological disorders; increasing usage of minimally invasive procedures; and the rising demand for antimicrobial catheters. Rising chronic disorders have become the most dominant cause of mortality and morbidity globally. According to the Brain Aneurysm Foundation in March 2021, globally, approximately 500,000 deaths are caused by brain aneurysms every year, and half of such individuals are aged 50 or below. The annual rate of rupture is around 8-10 people per 100,000 or about 30,000 people in United States. Thus, with the increasing prevalence of neurovascular disorders, the demand for neurovascular catheter devices is also anticipated to rise.

Furthermore, the growing number of minimally invasive procedures is expected to increase the demand for catheters worldwide. These procedures have increased patients' preference for less invasive procedures, which is expected to favor the market's growth. In addition, rising initiatives from the key market players for the launch of their products are expected to propel the market's growth further. For instance, in July 2021, Medtronic plc launched its Prevail drug-coated balloon (DCB) catheter in Europe following the CE (Conformite Europeenne) mark. The newest coronary DCB on the market, the Prevail DCB, is used during percutaneous coronary intervention (PCI) procedures to treat narrowed or blocked coronary arteries in patients with coronary artery disease (CAD). This will lead to increased adoption of such catheters to treat cardiovascular disease, and the market growth will benefit from rising minimally invasive procedure trends.

Hence, with the increasing number of surgeries being performed due to rising cases of chronic diseases, the demand for catheters is expected to increase in the near future, thereby driving the market's growth. However, complications associated with catheters and the presence of substitutes may hamper the growth of the market.

Key Market Trends

The Urology Catheters Segment is Expected to Hold a Major Revenue Share During the Forecast Period

A urinary catheter is found to be necessary for a person facing difficulty passing urine naturally. The segment is expected to show high growth during the forecast period owing to growing incidences of urological disorders as these products are used for patients who suffer from urological disorders.

The rising cases of COVID-19 have resulted in significant disruptions globally and have also impacted the demand for urinary catheters among the patient population. The urinary catheters were being used for surgical applications and the demand was impacted to some extent due to the temporary postponement of various elective surgeries, as authorities seek to ensure the availability of resources for COVID-19 patients. However, due to the rising infection rate, there were a few launches that have contributed to the segment's stable growth. Furthermore, according to the study titled "Prevalence and associated factors of urinary incontinence in women living in China: a literature review" published in October 2020, there were about 43-349 million Chinese women who had experienced urinary incontinence (UI). The growing prevalence of urinary incontinence and an increasing number of surgical procedures are the major factors driving the demand for urinary catheters, in turn boosting the segment's growth.

In addition, rising approvals for urinary catheters by regulatory agencies are further expected to boost this segment's growth during the forecast period. For instance, in November 2021, the Flume Catheter Company Ltd. (TFCC) received clearance from United States Food and Drug Administration (FDA) to market the FLUME urinary catheter in United States.

Thus, owing to the abovementioned factors, the urology catheter segment is expected to show growth over the forecast period.

North America is Expected to Hold a Significant Market Share During the Forecast Period

The North American region is expected to hold a significant market share in the catheters market during the forecast period. United States is expected to dominate the market due to the high government support for medical devices and an increasing number of surgeries. The other factors driving the market growth include the increasing prevalence of urological disorders, cardiovascular disorders, and the rising preference for minimally invasive procedures due to less operative time and fewer complications.

According to the American Cancer Society's 2022 statistics, there will be around 81,180 estimated new cases of bladder cancer in Americans in the year 2022. This will lead to increased adoption of catheters during the treatment of bladder cancer, thereby driving the market growth in this region.

Rising initiatives from the key market players for the launch of novel products are further expected to drive the market in this region. For instance, in March 2022, Cerus Endovascular received United States Food and Drug Administration (FDA) clearance for its 027 micro-catheters, available in two lengths, expanding its product portfolio, which includes the already FDA-cleared 021 micro-catheter platform. Likewise, in February 2021, Health Canada approved the TempSensor catheter designed by Bactguard.

Hence, growing product approvals coupled with the rapid increase in the patient pool in United States tend to increase the demand for catheters, which drives the overall growth of the market in the region.

Competitive Landscape

The catheters market is highly competitive as there have been a wide number of companies that have increased their focus on developing advanced catheters. Numerous manufacturers have collaborated with major medical device distributors to market and supply their products globally or in certain countries. Various established business players are also adopting numerous organic and inorganic growth strategies to increase their market shares. Also, product launches, mergers and acquisitions, and collaborations are the key strategies undertaken by these companies for sustainable growth. Some of the major players in this market include B. Braun Melsungen AG, Coloplast, ConvaTec Group, Hollister Incorporated, Medtronic PLC, Teleflex, and Boston Scientific Corporation, among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Burden of Cardiovascular, Neurological, and Urological Disorders
    • 4.2.2 Increasing Usage of Minimally Invasive Procedures
    • 4.2.3 Rising Demand for Antimicrobial Catheters
  • 4.3 Market Restraints
    • 4.3.1 Risks and Complications Associated with Catheters
    • 4.3.2 Presence of Substitutes
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product
    • 5.1.1 Cardiovascular Catheters
    • 5.1.2 Urology Catheters
    • 5.1.3 Intravenous Catheters
    • 5.1.4 Neurovascular Catheters
    • 5.1.5 Other Products
  • 5.2 By End User
    • 5.2.1 Hospitals
    • 5.2.2 Long Term Care Facilities​
    • 5.2.3 Other End Users
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 B. Braun Melsungen AG
    • 6.1.2 Coloplast
    • 6.1.3 ConvaTec Group​
    • 6.1.4 Hollister Incorporated
    • 6.1.5 Medtronic PLC
    • 6.1.6 Teleflex
    • 6.1.7 Boston Scientific Corporation
    • 6.1.8 Biotronik
    • 6.1.9 Abbott Laboratories
    • 6.1.10 Edwards Lifesciences Corporation
    • 6.1.11 Johnson & Johnson (DePuy Synthes)
    • 6.1.12 Terumo Corporation
    • 6.1.13 Becton, Dickinson and Company (C.R. Bard)

7 MARKET OPPORTUNITIES AND FUTURE TRENDS